Codes you report should reflect the services and drugs provided and documented. Do not guess every case will merit the same HCPCS codes.
HCPCS codesets, hcpcs codes, Medical Coding
The Stanford V regimen covers seven basic drugs; however the patient won't be getting all of those drugs each treatment day. In order to keep your coding straight, take advantage of this outline of what to expect.
Remember: The codes you report should reflect the services and drugs provided and documented. Do not guess every case will merit the same HCPCS codes.
Background: The aim in developing the Stanford V regimen for Hodgkin's lymphoma was to provide chemotherapy regimen that received high remission rates with fewer side effects than ABVD like pulmonary damage and sterility.
Depending on the stage of the disease, the patient may have radiation therapy as well.
Day 1: Watch for Mechlorethamine, Doxorubicin, and Vinblastine on the first day of the treatment cycle, the patient normally receives three of the drugs in the regimen.
Day 8: Check for Vincristine and Bleomycin
Staff normally adminsters two of the regimen's drugs on day 8.
Day 15: Add Etoposide to Doxorubicin and Vinblastine
The normal day 15 routine is similar to day 1; however it is not exactly the same. The patient again gets doxorubicin (J9000) and vinblastine (J9360), however does not receive mechlorethamine.
In its place, intravenous etoposide, a DNA toxin, is used.
Day 16: Repeat etoposide infusion
On day 16, the patient gets one more etoposide (J9181) infusion.
Day 22: Expect same as day 8
The drugs administered on day 22 are the same as day 8, with the patient receiving short infusions of vincristine (J9370, J9375, J9380) and bleomycin (J9040).
Everyday: Pay attention to P.O. Prednisone
Article source:-http://www.supercoder.com/coding-newsletters/my-oncology-hematology-coding-alert/infusion-coding-part-1-watch-hcpcs-to-clinch-clean-article
No comments:
Post a Comment